This is why I feel there are games being played here at the expense of people having to deal with the pandemic and the virus at large.
December 12, 2018
Generex Biotechnology Corporation (OTCQB:GNBT) today announced that the FDA had reviewed the company’s investigational new drug (IND) application and given notification that the study can proceed.
IND study approved~!
November 28, 2018
Announces Commercial Launch of FDA Approved Excellagen® , Proprietary, Patented Wound Care Product Focused on the Treatment of Complicated Wounds including Diabetic Ulcers and 16 Other FDA Approved Indications
Product approved~!
So, with two FDA approvals, one an IND study and the other a product, within a few days of one another, now the gates are closed? WTF~?
The pre-IND for The Complete Vaccine went better than anyone at Generex had ever seen. So what is the hold up? The SEC? Are you kidding me? How competent is THAT~?
Not very...... unless Big pharma (pssssst Pfizer) is behind the curtain. What a wonderful Wiz he is~! And we aren't in Kansas anymore
Dorothy. What a sh#t show bought and paid for.......
If it isn't the HFs screwing with your stock by naked shorting and dark pool trading then it's the competition paying someone to throw a monkey wrench into the works to sabotage a possibly better mouse trap.
I really hope I'm totally wrong about this.
Joe time to tell all.......... WTF is going on? TIA
And my opinion ....
AI
Market Data 
Markets 
